iCMLf Forum 2017: Perspectives on Treatment Free Remission: A global perspective

Topics include; cessation of tyrosine kinase inhibitor treatment in CML, STIM trial: molecular recurrence-free survival, summary of imatinib TFR studies and other TFR studies, molecular recurrence-free vs. treatment-free survival, TKI withdrawal syndrome, prognostic indicators of sustained TFR, STOP 2G TKI study results, DADI trial: TFR after discontinuation of dasatinib, what about second stop?.